Gentuity Collaborates With GE HealthCare to Market Intravascular Imaging Solutions in the United States

February 27, 2026—Gentuity LLC announced a commercial collaboration with GE HealthCare to increase the availability of Gentuity’s high-frequency optical coherence tomography (HF-OCT) imaging system and Vis-Rx Prime micro-imaging catheter.

As part of the collaboration, GE HealthCare will connect its cardiac catheterization lab customers in the United States with Gentuity products that are designed to enable precise planning and treatment for percutaneous coronary interventions (PCI), stated the company.

As noted in the press release, Gentuity’s HF-OCT imaging technology was featured alongside GE HealthCare’s portfolio of interventional solutions at TCT 2025 to highlight the potential for integrated imaging modalities and workflow optimization in the catheterization lab. The companies also plan to exhibit their products together at CRT 26, held March 7-10, advised Gentuity.

In October 2024, Gentuity announced FDA 510(k) clearance for its HF-OCT imaging system featuring the 1.8-F Vis-Rx catheter for assessment of coronary vessels both before and after PCI.